The study followed 38 immunocompromised adults, aged 64 to 72, who received either the Arexvy or Abrysvo RSV vaccine. Researchers found that people aged 60 and older who are immunocompromised ...

Researchers have shown that people 60 years or older with weakened immunity do not respond as strongly to vaccines against the respiratory syncytial virus (RSV) as people in the same age group with ...

Respiratory illness activity is currently considered "high" in the United States, according to the CDC. In one state, it is ...

Approximately 40% of participants did not seroconvert or achieve a conservative neutralization threshold post-vaccination.

BARS-13 is under clinical development by Beijing Advaccine Biotechnology and currently in Phase II for Respiratory Syncytial Virus (RSV) Infections.

ASC-60 is under clinical development by Sagimet Biosciences and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success rate ...

Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity—primarily organ transplant ...

New Hampshire was the state with the highest level of respiratory illness activity, according to the CDC. Americans can prevent the spread of viruses in several ways, such as staying home when they ...

Feeling ill after that Christmas or New Year's Eve party? If could be RSV. But how can you know for sure? Here are the symptoms to look for.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Two additional influenza-related flu deaths have been reported in Arkansas during the past week, raising the total for the ...

The emergence of Covid-19 five years ago marked one of the worst public health crises in modern history. During the ...